Scilex Pharmaceuticals, Inc.
Quick facts
Marketed products
- Lidocaine patch 1.8% · Pain management
Lidocaine blocks sodium channels in nerve fibers, interrupting pain signal transmission at the site of application. - ZTlido
Phase 3 pipeline
- SP-102 · Pain
SP-102 is a synthetic version of delta-9-tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis.
Phase 2 pipeline
Phase 1 pipeline
- Lidocaine medicated plaster 5%
- Lidocaine topical system 1.8%
- Naltrexone immediate release oral capsules
- SP-104
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: